Clearmind Medicine CMND 深 滬
等待開盤 09-20 09:30:00 美东时间
1.29
-0.030
-2.27%
華盛通- 最 高1.3425
- 今 開1.30
- 成交量 6.01万股
- 最 低 1.27
- 昨 收 1.32
- 總市值 420.73万
- 52周最高 10.35
- 市盈率 靜 --
- 換手率 1.84%
- 52周最低 0.9205
- 委 比 -99.10%
- 總股本 326.15万
- 歷史最高 183.00
- 量 比 0.71
- 振 幅 5.49%
- 歷史最低 0.9205
- 每 手 1
- 風險率 1.32%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Clearmind Medicine Files International Patent For Ibogaine Combination Therapy
Clearmind Medicine filed an international patent for a treatment that aims to enhance addiction treatment safety and efficacy.
09-18 00:31
SciSparc Unveils Breakthrough Ibogaine Therapy Patent
SciSparc Ltd. (SPRC) has released an update. SciSparc Ltd., a clinical-stage ph...
09-17 04:47
快讯 | 清明药品宣布荣幸地宣布先导性伊波盖因联合疗法的国际专利申请公告
Clearmind Medicine Announces the Notice of an International Patent Application ...
09-17 04:06
SciSparc and Clearmind Innovate Mental Health Treatment
SciSparc Ltd. (SPRC) has released an update. SciSparc Ltd., in collaboration wi...
09-07 23:34
快讯 | Scisparc-Clearmind医药合作导致申请创新的基于氯胺酮的联合用药的出版物
Scisparc-Clearmind Medicine Collaboration Leads to Publication of Application f...
08-30 04:25
快讯 | Clearmind Medicine和Yissum扩展合作，针对治疗精神障碍的第三代迷幻药物化合物提交国际专利申请。
Clearmind Medicine and Yissum Expand Collaboration With International Patent Ap...
08-17 04:14
Medical journal retracts three articles related to MDMA for PTSD
The journal Psychopharmacology on Aug. 10 retracted three articles related to the use of MDMA for PTSD, the day after the U.S. FDA rejected the use of the psychedlic drug for the condition. Scientists...
08-12 23:50
Psychedelic drug developers face setback as ecstasy-based drug rejected by FDA
The U.S. FDA has rejected privately-held Lykos Therapeutics' drug related to the psychedelic MDMA, also known as ecstasy, for PTSD. The issuing of a Complete Response Letter for midomafetamine is not ...
08-10 06:04
Why Doximity Shares Are Trading Higher By Over 28%; Here Are 20 Stocks Moving Premarket
Shares of Doximity, Inc. (NYSE:DOCS) rose sharply in today's pre-market trading...
08-09 17:04
SciSparc’s Innovative Therapy Shows Promise in Weight Loss
SciSparc Ltd. (SPRC) has released an update. SciSparc Ltd., in collaboration wi...
08-06 21:47
